TrialCancer research communications2026

CAR T-cell Kinetics, Persistence, and Clinical Outcomes in Adult Patients with Relapsed/Refractory B-cell ALL Treated with Obecabtagene Autoleucel in the FELIX Study.

Claire Roddie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.